Literature DB >> 15209431

Nurses, bowel continence, stigma, and taboos.

Christine Norton1.   

Abstract

This article explores why fecal incontinence remains a taboo subject and why it is often so difficult for patients to discuss their bowel symptoms. People's attitudes toward feces are complex and rooted in arbitrary social rules and conventions. It is difficult to encompass the full implications of fecal incontinence to those with this problem within a traditional medical model of illness and with cure as the goal of intervention. Many individuals are not cured, despite our best efforts. By recognizing the social dimension of this problem and by incorporating knowledge about coping and control into patient teaching and clinical practice, nurses may better meet the needs of those with fecal incontinence.

Entities:  

Mesh:

Year:  2004        PMID: 15209431     DOI: 10.1097/00152192-200403000-00008

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  10 in total

1.  Goals of fecal incontinence management identified by community-living incontinent adults.

Authors:  Amanda Manthey; Donna Z Bliss; Kay Savik; Ann Lowry; Robin Whitebird
Journal:  West J Nurs Res       Date:  2010-08       Impact factor: 1.967

2.  Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods.

Authors:  L Bartlett; M Nowak; Y H Ho
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

3.  Found in feces: differential diagnosis, workup, and treatment.

Authors:  Theodore A Stern; J Carl Pallais; Jeremiah M Scharf; Steven C Schlozman
Journal:  Prim Care Companion CNS Disord       Date:  2012-06-21

4.  Defective Conduction of Anorectal Afferents Is a Very Prevalent Pathophysiological Factor Associated to Fecal Incontinence in Women.

Authors:  Lluís Mundet; Christopher Cabib; Omar Ortega; Laia Rofes; Noemí Tomsen; Sergio Marin; Carla Chacón; Pere Clavé
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

5.  Health literacy and emotional responses related to fecal incontinence.

Authors:  Kristina Patel; Donna Z Bliss; Kay Savik
Journal:  J Wound Ostomy Continence Nurs       Date:  2010 Jan-Feb       Impact factor: 1.741

6.  Healthcare providers' perspectives on communicating incontinence and skin damage information with patients with dementia and their family caregivers: a descriptive study.

Authors:  Sharon Rolnick; Donna Z Bliss; Jody M Jackson; Casey Arntson; Jean Mullins; Kenneth Hepburn
Journal:  Ostomy Wound Manage       Date:  2013-04       Impact factor: 2.629

7.  Quality of Life Differences in Female and Male Patients with Fecal Incontinence.

Authors:  Lluís Mundet; Yolanda Ribas; Sandra Arco; Pere Clavé
Journal:  J Neurogastroenterol Motil       Date:  2016-01-31       Impact factor: 4.924

Review 8.  Assessing the stigma content of urinary incontinence intervention outcome measures.

Authors:  Kenneth Southall; Joshua R Tuazon; Abdul H Djokhdem; Eleanor A van den Heuvel; Walter Wittich; Jeffrey W Jutai
Journal:  J Rehabil Assist Technol Eng       Date:  2017-11-01

9.  The social, psychological, emotional morbidity and adjustment techniques for women with anal incontinence following Obstetric Anal Sphincter Injury: use of a word picture to identify a hidden syndrome.

Authors:  M R B Keighley; Yvette Perston; Elissa Bradshaw; Joanne Hayes; D Margaret Keighley; Sara Webb
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-21       Impact factor: 3.007

10.  Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.

Authors:  Christine Norton; Jonathan Syred; Sally Kerry; Micol Artom; Louise Sweeney; Ailsa Hart; Wladyslawa Czuber-Dochan; Stephanie J C Taylor; Borislava Mihaylova; Chris Roukas; Qasim Aziz; Laura Miller; Richard Pollok; Sonia Saxena; Imogen Stagg; Helen Terry; Zohra Zenasni; Lesley Dibley; Rona Moss-Morris
Journal:  Trials       Date:  2021-08-03       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.